A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers

ConditionHealthy Adult Volunteer

Trial statusNot yet recruiting

Trial phasePhase 1

Trial typeInterventional

Biological sexAll

Age19-50

SponsorDaewon Pharmaceutical Co., Ltd.

About this trial

Safety and pharmacokinetic characteristics evaluation of DW4421-T1 and DW4421S-T1

Eligibility criteria

Qualifiers

Healthy adult aged 19 to 50 (inclusive) years

Subjects weighing between 50 kg and 90 kg with BMI between 18 and 27 kg/m2 (inclusive)

Disqualifiers

clinical significant liver, kidney, nervous system, respiratory, endocrine, hematology and oncology, cardiovascular, urinary, and mental diseases or past history

Trial design

Treatments tested in this trial

DW4421-T1
DW4421S-T1

Treatment groups

38 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Daewon Pharmaceutical Co., Ltd.

Lead sponsor

Source ClinicalTrials.gov